Pharmaceutical Scientists' Salaries in 2023
2024年1月15日 · Last October, the American Association of Pharmaceutical Scientists (AAPS) released its annual salary survey, which measures the earnings of individuals working in pharmaceutical sciences in the U.S., both in academia and industry.I expected the survey to reflect the harsh funding environment, layoffs, and inflation rate that impacted so many people working in the preceding 12 months.
Life Science Leader - Home Page
Life Science Leader - thought leadership articles and discussions about the current life science industry
Merck's Continuous Process Improvement - Life Science Leader
2014年7月1日 · By Gail Dutton, Contributing Writer Follow Me On Twitter @GailLdutton. Continuous improvement doesn’t just depend upon Lean principles and/or zero-based budgeting. It depends upon people inspired by a culture that values learning, promotes problem-solving skills, and strives toward big goals by making small improvements every day.
Where Are They Now? SQZ Biotech - lifescienceleader.com
2024年5月1日 · By Ben Comer, Chief Editor, Life Science Leader. Armon Sharei. Then: In the March 2019 issue of Life Science Leader, SQZ Biotech cofounder and CEO Armon Sharei, Ph.D., reflected on his initial attraction to an MIT project led by Professor Klavs Jensen: delivering materials into cells using a microfluidic gun. “Imagine a miniaturized, high-powered squirt gun designed to fire things into cells ...
The Story Of Pfizer's R&D Turnaround - Life Science Leader
2019年8月30日 · By Rob Wright, Chief Editor, Life Science Leader Follow Me On Twitter @RfwrightLSL. Mikael Dolsten “I was surprised at the magnitude of the challenge faced by Pfizer at the end of 2009, particularly in R&D,” recalls Mikael Dolsten, M.D., Ph.D., who is now the company’s chief scientific officer and president, worldwide research, development and …
Why Regulatory Intelligence Is More Important Than Ever
2013年4月1日 · By Cathy Yarbrough, Contributing Editor Follow Me On Twitter @sciencematter. When FDA official Robert Temple, M.D., speaks at the agency’s opento- the-public workshops and other meetings, Gary Buehler, VP of global regulatory intelligence and policy at Teva Pharmaceuticals, listens.
How Tony Robbins Became An Investor In Celularity - Life Science …
2019年7月22日 · By Rob Wright, Chief Editor, Life Science Leader Follow Me On Twitter @RfwrightLSL. Peter Diamandis, M.D., founder and executive chairman the XPRIZE Foundation (L), Tony Robbins and Robert Hariri, M.D., Ph.D., cofounder and CEO of Celularity Therapeutics.
Life Science Connect Podcast
2021年6月25日 · 029: The Effects Of Politics On Pharma According to Outsourced Pharma Chief Editor, Louis Garguilo, “politics has never played a bigger role in our (global) biopharma industry.” In this episode, we talk with Louis about three of his recent editorials that touch on this subject while also discussing the current IP debate in pharma and the origins of the coronavirus.
Quality Agreements In Clinical Development A Road Map Toward …
2014年12月24日 · <p>With clinical research continuing the trend of outsourcing more clinical trial activities to clinical service providers such as CROs or other vendors, it has become critical for sponsors to ensure that the activities they have outsourced are performed in accordance with the sponsor’s quality expectations. Because of shortened development timelines, often after a rigorous selection ...
Using SharePoint In A Regulated Environment - Life Science Leader
2009年7月4日 · <p> The regulatory landscape is constantly changing and requires a greater number of businesses to demonstrate compliance. The compliance landscape for most organizations consists of either Sarbanes-Oxley (SOX), Health Insurance Portability and Accountability Act (HIPAA), or the FDA’s Code of Federal Regulations (CFR) 21 Part 11 regarding electronic records and electronic signatures.</p>